Form S-1 Felicitex Therapeutics
Tweet
Share
E-mail
http://archive.fast-edgar.com/20220810/AJ2JA22CLZ22V92V22992ZY2OVDQZ222Z242
Filed on: August 10, 2022
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies Starts Nuvalent (NUVL) at Buy, 'Precisely Targeted Oncology Aiming for Firstline Treatment'
- Stifel Downgrades Saipem (SPM:IM) (SAPMY) to Hold
- Allarity Therapeutics (ALLR) Granted Nasdaq Extension to Regain Compliance
Create E-mail Alert Related Categories
SEC FilingsRelated Entities
S1Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
